Marc Alan Brenner, DPM, FASPD | Podiatric Physician

With thirty years experience as a practicing podiatric physician, and special expertise in Diabetic Foot Management, Dr. Brenner has played a key role in the podiatric community. He is a renowned national and international lecturer as well as a consultant to major institutions in the areas of podiatric dermatology and diabetic foot management. Dr. Brenner is the Editor of the textbook Management of the Diabetic Foot, Williams & Wilkins Publisher. He is a member of the American Podiatric Medical Association. Author and editor of numerous publications, Dr. Brenner has over 250 lectures, videos and nationwide radio/television tours to his credit. He is Board Certified in podiatric medicine and is presently on the medical staff of North Shore Hospital and Long Island Jewish Hospital, both in Long Island, New York.


Doctor of Podiatric Medicine
New York College of Podiatric Medicine

Board Certification

American Board of Podiatric Orthopedics & Primary Podiatric Medicine


Fellow and Past President of the American Society of Podiatric Dermatology
American Podiatry Association
New York State Podiatric Association

Authorship Texts and Monographs

Management of the Diabetic Foot
Infections and Other Disorders of the Lower Extremities

Return to Gensco Leadership Team Page »

Gensco Medical Advisory Board

James R. Andrews, MD | Orthopedic Surgeon   bio »

Gary E. Myerson, MD | Rheumatologist   bio »

Alesia Wagner, DO, FACOFP | Associate Professor, Primary Care   bio »

Marc Alan Brenner, DPM | Podiatrist   bio »

Return to Gensco Leadership Team Page »


Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAPORT® (Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in development and commercialization of prescription more...

Looking To The Future

A single dose topical colchinium for acute gout flares.